A research group led by Claus M. Azzalin at iMM has discovered that a human enzyme named FANCM is absolutely required for the survival of ALT tumor cells. The results were now published in the open access journal Nature Communications. Future strategies targeting the activity of this molecule in ALT tumor cells can constitute the basis of a novel therapeutic protocol for the treatment of these tumors.
from EurekAlert! - Breaking News http://bit.ly/30QFVAL
via IFTTT
Tuesday, May 28, 2019
New study reveals an unexpected survival mechanism of a subset of cancer cells
About Admin -
Author Description here.. Nulla sagittis convallis. Curabitur consequat. Quisque metus enim, venenatis fermentum, mollis in, porta et, nibh. Duis vulputate elit in elit. Mauris dictum libero id justo.